MMTX.SW stock up 12.66% to CHF 1.21 on 02 Feb 2026 (SIX): short-term outlook and key metrics

MMTX.SW stock climbed 12.66% to CHF 1.21 on 02 Feb 2026 at the close on the SIX Swiss Exchange. The rise came on 365,646 shares, below the 50‑day average of 487,347, but well above the prior session price. MindMaze Therapeutics Holding S.A. (MMTX.SW) is a small‑cap biotech listed in Switzerland. Today’s move outpaced the Healthcare sector, which was essentially flat. We break down price action, valuation gaps, technical signals and a model forecast to frame short‑term opportunity and risk.